Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Quanwei Tao"'
Publikováno v:
Stem Cells International, Vol 2016 (2016)
Mesenchymal stromal cells (MSCs) are promising candidates for regenerative medicine because of their multipotency, immune-privilege, and paracrine properties including the potential to promote angiogenesis. Accumulating evidence suggests that the inh
Externí odkaz:
https://doaj.org/article/5c6a7afd47d14961a3875cd633be8835
Autor:
Xiangyang Xia, Jian-an Wang, Hong Yu, Keith A. Webster, Quanwei Tao, Kai Lu, Norman L. Block, Andrew V. Schally, Jian Shen, Qiyuan Xu, Yao Liang Tang, Qunchao Ma, Xinyang Hu
Objective— The efficiency of cell therapy is limited by poor cell survival and engraftment. Here, we studied the effect of the growth hormone–releasing hormone agonist, JI-34, on mesenchymal stem cell (MSC) survival and angiogenic therapy in a mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b9f4d0003ce89185af725a9b8d786a
https://europepmc.org/articles/PMC4808467/
https://europepmc.org/articles/PMC4808467/
Autor:
Hong Yu, Qunchao Ma, Xiangyang Xia, Quanwei Tao, Kai Lu, Jian Shen, Norman Block, Keith Webster, Jian’an Wang, Andrew V Schally
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 35
Transplantation of bone marrow-derived mesenchymal stem cells (MSCs) represents a promising strategy for treating cardiovascular disease. However, the efficiency of such therapy is limited by poor cell survival and engraftment. Growth hormone-releasi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f0003f2f782254747517b09d1c13b01
https://doi.org/10.1161/atvb.35.suppl_1.723
https://doi.org/10.1161/atvb.35.suppl_1.723
Autor:
QunChao Ma, Xiangyang Xia, Quanwei Tao, Kai Lu, Jian Shen, Qiyuan Xu, Xinyang Hu, Yaoliang Tang, Block, Norman L., Webster, Keith A., Schally, Andrew V., Jian'an Wang, Hong Yu
Publikováno v:
Arteriosclerosis, Thrombosis & Vascular Biology; Apr2016, Vol. 36 Issue 4, p663-672, 10p